Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Testicular Neoplasms × Dactinomycin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Sarcoma 15 Rhabdomyosarcoma 12 Malignant mesenchymal tumor 6 Gestational Trophoblastic Disease 6 Wilms Tumor 5 Neuroectodermal Tumors, Primitive, Peripheral 3 Melanoma 3 Kidney Neoplasms 3 Sarcoma, Ewing 2 Rhabdomyosarcoma, Embryonal 2 Ovarian Neoplasms 2 Hydatidiform Mole 2 Fibrosarcoma 2 Choriocarcinoma 2 Testicular Neoplasms 1 Teratoma, Ovarian 1 Sarcoma, Alveolar Soft Part 1 Rhabdomyosarcoma, Alveolar 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleuropulmonary blastoma 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Lymphoma 1 Liposarcoma 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia 1 Hydatidiform Mole, Invasive 1 Histiocytoma, Malignant Fibrous 1 Hemangiosarcoma 1 Hemangiopericytoma, Malignant 1

Interventions

Carboplatin 24 Etoposide 22 Filgrastim 18 Ifosfamide 17 Cisplatin 16 Peripheral Blood Stem Cell Transplantation 14 Paclitaxel 13 Cyclophosphamide 10 Bleomycin 8 Radiotherapy 7 Magnetic Resonance Spectroscopy 6 Gemcitabine 6 Thiotepa 5 Therapeutics 5 Polymerase Chain Reaction 5 Granulocyte Colony-Stimulating Factor 5 Flow Cytometry 5 Temozolomide 4 Melphalan 4 Busulfan 4 sargramostim 3 etoposide phosphate 3 Psychiatric Rehabilitation 3 Oxaliplatin 3 Methylprednisolone 3 Methods 3 Fluorodeoxyglucose F18 3 Epirubicin 3 Dexamethasone 3 Blood Specimen Collection 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06309732 2024-03-13

GAMEC-II

Queen Mary University of London

Phase 2 Completed

Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡